Barrington analyst Michael Petusky maintained a Hold rating on US Physical Therapy (USPH) today. The company’s shares closed yesterday at $133.84, close to its 52-week high of $135.01.
Petusky noted:
“We are maintaining our MARKET PERFORM investment rating on USPH shares due to valuation concerns. The stock is currently trading at around 24.8x EV/EBITDA (relative to our 2019 estimate). While we really like the company and its management, such a valuation still seems stretched. We realize that we have missed a lot of the run-up in this idea over the past several quarters, but we continue to hope for a cheaper entry point.”
According to TipRanks.com, Petusky is a 3-star analyst with an average return of 3.5% and a 49.4% success rate. Petusky covers the Healthcare sector, focusing on stocks such as Anika Therapeutics Inc, Varian Medical Systems, and Merit Medical Systems.
US Physical Therapy has an analyst consensus of Hold.
See today’s analyst top recommended stocks >>
Based on US Physical Therapy’s latest earnings release for the quarter ending March 31, the company reported a quarterly net profit of $5.01 million. In comparison, last year the company had a net profit of $6.04 million.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
U.S. Physical Therapy, Inc. operates outpatient physical therapy clinics, which provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries. The company was founded in 1990 and is headquartered in Houston, TX.
